334 related articles for article (PubMed ID: 25239128)
1. Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.
Hill L; McIlfatrick S; Taylor B; Dixon L; Harbinson M; Fitzsimons D
Palliat Med; 2015 Apr; 29(4):310-23. PubMed ID: 25239128
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study.
Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; van Bruchem-Visser RL; Theuns DA; Bhagwandien RE; Van der Heide A; Rietjens JA
Heart; 2020 Feb; 106(3):190-195. PubMed ID: 31537636
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
[TBL] [Abstract][Full Text] [Related]
4. Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.
Herman M; Horner K; Ly J; Vayl Y
J Hosp Palliat Nurs; 2018 Feb; 20(1):63-71. PubMed ID: 30063615
[TBL] [Abstract][Full Text] [Related]
5. Spouses' reflections on implantable cardioverter defibrillator treatment with focus on the future and the end-of-life: a qualitative content analysis.
Fluur C; Bolse K; Strömberg A; Thylén I
J Adv Nurs; 2014 Aug; 70(8):1758-69. PubMed ID: 24321029
[TBL] [Abstract][Full Text] [Related]
6. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
Russo JE
Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
[TBL] [Abstract][Full Text] [Related]
8. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
Thylén I; Moser DK; Strömberg A
BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
[TBL] [Abstract][Full Text] [Related]
9. Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study.
MacIver J; Tibbles A; Billia F; Ross H
SAGE Open Med; 2016; 4():2050312116642693. PubMed ID: 27110361
[TBL] [Abstract][Full Text] [Related]
10. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences.
Lee MC; Sulmasy DP; Gallo J; Kub J; Hughes MT; Russell S; Kellogg A; Owens SG; Terry P; Nolan MT
Am J Hosp Palliat Care; 2017 Jul; 34(6):518-523. PubMed ID: 27034436
[TBL] [Abstract][Full Text] [Related]
11. Patients' openness to discussing implantable cardioverter defibrillator deactivation at end of life: a cross-sectional study.
Lee KS; Oh O; Miller J; Hammash M; Thompson DR; Ski CF; Cameron J; Hwang SY; Moser DK
Eur J Cardiovasc Nurs; 2022 Oct; 21(7):687-693. PubMed ID: 35018427
[TBL] [Abstract][Full Text] [Related]
12. Moral Distress at the End of a Life: When Family and Clinicians Do Not Agree on Implantable Cardioverter-Defibrillator Deactivation.
Steiner JM; Patton KK; Prutkin JM; Kirkpatrick JN
J Pain Symptom Manage; 2018 Feb; 55(2):530-534. PubMed ID: 29191724
[TBL] [Abstract][Full Text] [Related]
13. Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.
Gonzalez-Jaramillo V; Sobanski P; Calvache JA; Arenas-Ochoa LF; Franco OH; Hunziker L; Eychmüller S; Maessen M
Palliat Med; 2020 Sep; 34(8):1019-1029. PubMed ID: 32588755
[TBL] [Abstract][Full Text] [Related]
14. Advance care planning and end-of-life care in patients with an implantable cardioverter defibrillator: The perspective of relatives.
Stoevelaar R; Stoppelenburg A; van Bruchem-Visser RL; van Driel AG; Theuns DA; Lokker ME; Bhagwandien RE; Heide AV; Rietjens JA
Palliat Med; 2021 May; 35(5):904-915. PubMed ID: 33845683
[TBL] [Abstract][Full Text] [Related]
15. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
Daeschler M; Verdino RJ; Kirkpatrick JN
Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
[TBL] [Abstract][Full Text] [Related]
16. Implantable cardioverter defibrillator devices: when, how and who should discuss deactivation with patients: a systematic literature review.
Freemantle M; Murtagh F
BMJ Support Palliat Care; 2022 Dec; 12(4):359-367. PubMed ID: 33963003
[TBL] [Abstract][Full Text] [Related]
17. [Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].
Romanò M; Piga MA; Bertona R; Negro R; Ruggeri C; Zorzoli F; Villani R
G Ital Cardiol (Rome); 2017 Feb; 18(2):139-149. PubMed ID: 28398367
[TBL] [Abstract][Full Text] [Related]
18. Normativity under change: Older persons with implantable cardioverter defibrillator.
Svanholm JR; Nielsen JC; Mortensen PT; Christensen CF; Birkelund R
Nurs Ethics; 2016 May; 23(3):328-38. PubMed ID: 25566813
[TBL] [Abstract][Full Text] [Related]
19. Implantable cardioverter defibrillator (ICD) functionality: patient and family information for advanced decision-making.
Hill LM; McIlfatrick S; Taylor B; Dixon L; Fitzsimons D
BMJ Support Palliat Care; 2022 Jul; 12(e2):e219-e225. PubMed ID: 31771959
[TBL] [Abstract][Full Text] [Related]
20. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
